These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25312240)

  • 1. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods.
    Grobelny P; Kazakevich I; Zhang D; Bogner R
    Pharm Dev Technol; 2015 Jan; 20(1):118-27. PubMed ID: 25312240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.
    Bahl D; Bogner RH
    Pharm Res; 2006 Oct; 23(10):2317-25. PubMed ID: 16927179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding.
    Bahl D; Hudak J; Bogner RH
    Pharm Dev Technol; 2008; 13(3):255-69. PubMed ID: 18484494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-step continuous extrusion process for the manufacturing of solid dispersions.
    Maniruzzaman M; Nair A; Scoutaris N; Bradley MS; Snowden MJ; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):42-51. PubMed ID: 26403386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of solid SEDDS, VI: Effect of precoating of Neusilin
    Gumaste SG; Freire BOS; Serajuddin ATM
    Eur J Pharm Sci; 2017 Dec; 110():124-133. PubMed ID: 28212981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Nanometric Solid Dispersions of Glibenclamide in Neusilin(®) UFL2.
    Censi R; Gigliobianco MR; Dubbini A; Malaj L; Di Martino P
    AAPS PharmSciTech; 2016 Oct; 17(5):1204-12. PubMed ID: 26645108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2.
    Shah A; Serajuddin AT
    Int J Pharm; 2015 Apr; 484(1-2):172-80. PubMed ID: 25724137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.
    Vadher AH; Parikh JR; Parikh RH; Solanki AB
    AAPS PharmSciTech; 2009; 10(2):606-14. PubMed ID: 19444620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery.
    Bolko Seljak K; Ilić IG; Gašperlin M; Zvonar Pobirk A
    Int J Pharm; 2018 Sep; 548(1):263-275. PubMed ID: 29969713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of taste masked ondansetron-magnesium aluminum silicate adsorption systems.
    Kharb V; Saharan VA; Kharb V; Jadhav H; Purohit S
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1291-9. PubMed ID: 26641930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the liquisolid technique and co-milling for loading of a poorly soluble drug in inorganic porous excipients.
    Ogadah CU; Mrštná K; Matysová L; Müllertz A; Rades T; Niederquell A; Šklubalová Z; Vraníková B
    Int J Pharm; 2024 Jan; 650():123702. PubMed ID: 38086492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dissolution rates of tranilast solid dispersions extruded with inorganic excipients.
    Maniruzzaman M; Ross SA; Islam MT; Scoutaris N; Nair A; Douroumis D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):947-957. PubMed ID: 28122459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric use.
    Lou H; Liu M; Wang L; Mishra SR; Qu W; Johnson J; Brunson E; Almoazen H
    AAPS PharmSciTech; 2013 Sep; 14(3):950-8. PubMed ID: 23761262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of physically stable amorphous drugs by milling with Neusilin.
    Gupta MK; Vanwert A; Bogner RH
    J Pharm Sci; 2003 Mar; 92(3):536-51. PubMed ID: 12587115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and Physical Property Optimization of an Amorphous Drug Substance Utilizing a High Surface Area Magnesium Aluminometasilicate (Neusilin(®) US2).
    Allgeier MC; Piper JL; Hinds J; Yates MH; Kolodsick KJ; Meury R; Shaw B; Kulkarni MR; Remick DM
    J Pharm Sci; 2016 Oct; 105(10):3105-3114. PubMed ID: 27492963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential application of low molecular weight excipients for amorphization and dissolution enhancement of carvedilol.
    Pešić N; Dapčević A; Ivković B; Kachrimanis K; Mitrić M; Ibrić S; Medarević D
    Int J Pharm; 2021 Oct; 608():121033. PubMed ID: 34419592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and characterization study of itraconazole-loaded microparticles.
    Segale L; Giovannelli L; Mannina P; Pattarino F
    Pharm Dev Technol; 2015 Mar; 20(2):153-8. PubMed ID: 24219826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preformulation studies on solid self-emulsifying systems in powder form containing magnesium aluminometasilicate as porous carrier.
    Krupa A; Szlęk J; Jany BR; Jachowicz R
    AAPS PharmSciTech; 2015 Jun; 16(3):623-35. PubMed ID: 25501870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.